Leonard Yaffe's  Instablog

Leonard Yaffe
Send Message
I am an MD by background who runs a healthcare hedge fund. I worked as a sell-side medical analyst for 20 years, covering pharmaceuticals, medical devices, PBMs and drug distributors.
  • Medical Device Industry Consolidation To Continue 1 comment
    Jun 16, 2014 6:26 PM | about stocks: MDT, KMB, SYK, BDX, HSP

    I think the most underappreciated factors behind the consolidation in the medical device sector are the favorable growth of the healthcare industry (6% vs 2.5% for US GDP), which allows for long-term planning, and the consolidation that is happening on the provider side at the local and national levels. The latter occurrence puts a premium on product line breadth and economies of scale. It is much more than the ACA...it is also hospitals buying doctor practices and health systems merging. I would expect this trend to continue. Note that I forecast industry growth to increase to its more normalized rate of 6%, given the implementation of the ACA (more people with insurance accessing the system) and the improved economy, which contrasts with the immediate prior period when people delayed non-emergent medical procedures.

    For the past two years I have been recommending commodity medical company stocks, due to the reasons cited above, Covidien is an excellent example of such a company. Other possible buyout candidates include HSP, SYK, KMB (healthcare division) and BDX.

    Disclosure: The author is long KMB, SYK, BDX, HSP.

    Stocks: MDT, KMB, SYK, BDX, HSP
Back To Leonard Yaffe's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (1)
Track new comments
  • danleeg
    , contributor
    Comments (209) | Send Message
    Healthcare M&A has been fun to follow... and consolidation is a great thing for shareholders! I am long VHT & IBB. Also long TBPH & THRX (...GSK needs to buy at least one!)
    16 Jun 2014, 09:19 PM Reply Like
Full index of posts »
Latest Followers


  • $GILD Gilead Anthem deal, if no patient exclusions (ie fibrosis stage), is another example of trading volume for price. Win-win. BUY GILD
    Jan 8, 2015
  • Is There A New Reality To The Drug Industry? http://seekingalpha.com/a/1nid5
    Dec 23, 2014
  • Update: News On Gilead From The California Technology Assessment Forum $GILD http://seekingalpha.com/a/1nbxr
    Dec 19, 2014
More »

Latest Comments

Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.